Skinhealth Systems - Class A (SKIN) closed at $10.35 on November 3, 2026, down 0.3% from the previous close, on volume of 24,716 shares (30-day average 193,281).
Data as of November 3, 2026.
3-Nov-2026
SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026
Globe Newswire (Thu, 22-Oct 10:00 AM ET)
SkinHealth Systems Announces Reverse Stock Split
Globe Newswire (Fri, 9-Oct 9:00 AM ET)
Hydrafacial Introduces HydraClear Treatment Booster to Clarify Blemish-Prone Skin
Globe Newswire (Tue, 6-Oct 8:00 AM ET)
SkinHealth Systems Expands SkinStylus SteriLock MicroSystem to Europe
Globe Newswire (Thu, 1-Oct 3:00 AM ET)
Globe Newswire (Tue, 15-Sep 9:00 AM ET)
Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers
Globe Newswire (Tue, 8-Sep 9:00 AM ET)
SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth
Globe Newswire (Wed, 26-Aug 8:00 AM ET)
SkinHealth Systems Reports Second Quarter 2026 Financial Results
Globe Newswire (Thu, 6-Aug 4:05 PM ET)
SkinStylus Wins FDA Clearance for Periorbital Wrinkles—A New Benchmark in Microneedling Technology
Market Chameleon (Tue, 7-Jul 6:28 AM ET)
Market Chameleon (Fri, 13-Mar 7:09 AM ET)
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
Skinhealth Systems - Class A trades on the NASDAQ stock market under the symbol SKIN.
As of November 3, 2026, SKIN stock price declined to $10.35 with 24,716 million shares trading.
SKIN has a beta of 1.76, meaning it tends to be more sensitive to market movements. SKIN has a correlation of 0.07 to the broad based SPY ETF.
SKIN has a market cap of $67.43 million. This is considered a Micro Cap stock.
Last quarter Skinhealth Systems - Class A reported $72 million in Revenue and -$.40 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.20.
In the last 3 years, SKIN traded as high as $103.40 and as low as $9.68.
The top ETF exchange traded funds that SKIN belongs to (by Net Assets): VTI, VXF.
SKIN has underperformed the market in the last year with a price return of -63.8% while the SPY ETF gained +11.7%. SKIN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.5% and -1.9%, respectively, while the SPY returned +1.2% and -1.6%, respectively.
SKIN support price is $9.58 and resistance is $11.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SKIN shares will trade within this expected range on the day.